Cargando…

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy

Pattern recognition receptors (PRRs) play a crucial role in the innate immune system and contribute to host defense against microbial infection. PRR-mediated antimicrobial signals provide robust type-I IFN/cytokine production and trigger inflammation, thereby affecting tumor progression and autoimmu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Misako, Takeda, Yohei, Tatematsu, Megumi, Seya, Tsukasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742578/ https://www.ncbi.nlm.nih.gov/pubmed/29312355 http://dx.doi.org/10.3389/fimmu.2017.01897

Ejemplares similares

Adjuvant for vaccine immunotherapy of cancer – focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity
por: Seya, Tsukasa, et al.
Publicado: (2015)

Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide
por: Takeda, Yohei, et al.
Publicado: (2018)

Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model
por: Yoshida, Sumito, et al.
Publicado: (2018)

Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy
por: SEYA, Tsukasa, et al.
Publicado: (2018)

Pan-Vertebrate Toll-Like Receptors During Evolution
por: Oshiumi, Hiroyuki, et al.
Publicado: (2008)

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies
por: Seya, Tsukasa, et al.
Publicado: (2006)

Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement
por: Seya, Tsukasa, et al.
Publicado: (2022)

Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells
por: Shime, Hiroaki, et al.
Publicado: (2017)

Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy
por: Takeda, Yohei, et al.
Publicado: (2016)

Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy
por: Yoshida, Sumito, et al.
Publicado: (2019)

UNC93B1 Physically Associates with Human TLR8 and Regulates TLR8-Mediated Signaling
por: Itoh, Hiroki, et al.
Publicado: (2011)

Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
por: Iwakiri, Dai, et al.
Publicado: (2009)

Toll-Like Receptor-4 Modulation for Cancer Immunotherapy
por: Awasthi, Shanjana
Publicado: (2014)

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies
por: Muccioli, Maria, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models
por: Takeda, Yohei, et al.
Publicado: (2018)

Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2023)

Toll-Like Receptor Signaling Pathways
por: Kawasaki, Takumi, et al.
Publicado: (2014)

Two Modes of Th1 Polarization Induced by Dendritic-Cell-Priming Adjuvant in Vaccination
por: Seya, Tsukasa, et al.
Publicado: (2023)

Understanding the role of Toll-like receptors in lung cancer immunity and immunotherapy
por: Hoden, Bettina, et al.
Publicado: (2022)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

Dendritic Cells from Oral Cavity Induce Foxp3(+) Regulatory T Cells upon Antigen Stimulation
por: Yamazaki, Sayuri, et al.
Publicado: (2012)

Dysregulated Responsiveness of Circulating Dendritic Cells to Toll-Like Receptors in ANCA-Associated Vasculitis
por: Braudeau, Cécile, et al.
Publicado: (2017)

Subverting Toll-Like Receptor Signaling by Bacterial Pathogens
por: McGuire, Victoria A., et al.
Publicado: (2015)

A Role for Syntaxin 3 in the Secretion of IL-6 from Dendritic Cells Following Activation of Toll-Like Receptors
por: Collins, Laura E., et al.
Publicado: (2015)

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells
por: Guo, Xueheng, et al.
Publicado: (2017)

The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc(Min/+) mice
por: Ono, Junya, et al.
Publicado: (2017)

Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
por: Chuang, Yu-Chen, et al.
Publicado: (2020)

Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells
por: Hirsch, Ivan, et al.
Publicado: (2017)

Roles of Toll-Like Receptor 3 in Human Tumors
por: Zheng, Xin, et al.
Publicado: (2021)

TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis
por: Seya, Tsukasa, et al.
Publicado: (2012)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses
por: Nijen Twilhaar, Maarten K., et al.
Publicado: (2022)

Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells
por: Azuma, Masahiro, et al.
Publicado: (2012)

Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease
por: Rip, Jasper, et al.
Publicado: (2019)

Contribution of Aberrant Toll Like Receptor Signaling to the Pathogenesis of Myelodysplastic Syndromes
por: Paracatu, Luana Chiquetto, et al.
Publicado: (2020)

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
por: Duan, Tianhao, et al.
Publicado: (2022)

Toll-Like Receptors of Deuterostome Invertebrates
por: Satake, Honoo, et al.
Publicado: (2012)

Toll-Like Receptors and Skin Cancer
por: Burns, Erin M., et al.
Publicado: (2014)

Toll-Like Receptors and Prostate Cancer
por: Zhao, Shu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7btpduanbuutpu77h9c9f83d9n